Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PAVM - PAVmed Inc.

IEX Last Trade
0.6
-0.019   -3.150%

Share volume: 211,138
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing : -0.22%

PREVIOUS CLOSE
CHG
CHG%
$0.62
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
26%
Profitability 43%
Dept financing 33%
Liquidity 21%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.27%
1 Month
-16.71%
3 Months
-45.45%
6 Months
-36.17%
1 Year
-78.95%
2 Year
-93.16%
Key data
Stock price
$0.60
P/E Ratio 
0.87
DAY RANGE
$0.59 - $0.65
EPS 
-$7.16
52 WEEK RANGE
$0.62 - $3.50
52 WEEK CHANGE
-$78.95
MARKET CAP 
12.800 M
YIELD 
N/A
SHARES OUTSTANDING 
10.406 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$205,699
AVERAGE 30 VOLUME 
$325,911
Company detail
CEO: Lishan Aklog
Region: US
Website: pavmed.com
Employees: 90
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE)

Recent news